APA (7th ed.) Citation

T, D., EA, A., N, C., RH, W., A, S., & ED, E. (2026). Ribociclib is not a substrate or inhibitor of Oatp1b-mediated uptake in vivo. Cancer chemotherapy and pharmacology, 96(1), . https://doi.org/10.1007/s00280-026-04877-x

Chicago Style (17th ed.) Citation

T, Drabison, Ahmed EA, Colasanti N, Weber RH, Sparreboom A, and Eisenmann ED. "Ribociclib Is Not a Substrate or Inhibitor of Oatp1b-mediated Uptake in Vivo." Cancer Chemotherapy and Pharmacology 96, no. 1 (2026). https://doi.org/10.1007/s00280-026-04877-x.

MLA (9th ed.) Citation

T, Drabison, et al. "Ribociclib Is Not a Substrate or Inhibitor of Oatp1b-mediated Uptake in Vivo." Cancer Chemotherapy and Pharmacology, vol. 96, no. 1, 2026, https://doi.org/10.1007/s00280-026-04877-x.